ISHITA DRUGS & INDUSTRIES LTD. Share Price

ISHITA DRUGS & INDUSTRIES LTD. Share Price

BSE: 524400
|
Pharmaceuticals
|
S Cap
₹ 73.50
+₹0.52 (0.71%)
1D
Last updated 23 Sep, 2026, 12:20 IST

ISHITA DRUGS & INDUSTRIES LTD. Share Price Today

As of 23 Sep 2026, ISHITA DRUGS & INDUSTRIES LTD. share price is ₹73.50. The stock opened at ₹72.41, compared to its previous close of ₹72.98. During today's trading session, ISHITA DRUGS & INDUSTRIES LTD. share price moved in the range of ₹72.41 to ₹73.50, with an average price of ₹72.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹66.00 and a high of ₹90.85.

₹72.41
0.71% up today
₹73.50
1D LOW
1D HIGH

ISHITA DRUGS & INDUSTRIES LTD. Returns Calculator

Circuit
L
H
₹58.39
₹87.57
52-week
L
H
₹66.00
₹90.85

About ISHITA DRUGS & INDUSTRIES LTD.

ISHITA DRUGS & INDUSTRIES LTD. Share Price
ISIN
INE806D01016
Sector Market Cap
₹ 21.82 Cr

Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, and methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.

ISHITA DRUGS & INDUSTRIES LTD. Financial Highlights

  • Revenue: ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹15.13 crore in FY26 vs ₹15.34 crore in FY25. It showed a decrease of 1.37% on a yearly basis.
  • Operating Profit: ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹1.08 crore in FY26 vs ₹1.16 crore in FY25. It showed a decrease of 6.90% on a year-on-year basis.
  • Net Profit: ISHITA DRUGS & INDUSTRIES LTD. reported a net profit of ₹0.78 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 10.34% on a yearly basis.

ISHITA DRUGS & INDUSTRIES LTD. Quarterly Result Highlights

  • ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹3.19 crore in Jun 2026, compared with ₹3.28 crore in Mar 2026, representing a decrease of 2.74% on a quarter-on-quarter (QoQ) basis.
  • ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹0.30 crore in Jun 2026, compared with ₹0.28 crore in Mar 2026, representing an increase of 7.14% on a quarter-on-quarter (QoQ) basis.
  • ISHITA DRUGS & INDUSTRIES LTD. reported a profit of ₹0.23 crore in Jun 2026, compared with ₹0.18 crore in Mar 2026, reflecting an increase of 27.78% on a QoQ basis.
  • The earnings per share (EPS) of ISHITA DRUGS & INDUSTRIES LTD. stood at ₹2.60 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.04%
FII
0.00%
Other DII
0.00%
Retail and other
49.96%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
21.82
P/E
30.92
P/B
1.89
ROE
6.73%
D/E
0.01
ROCE
9.78%
Div. Yield
0.00%
EPS(TTM)
2.60
Turnover
0.99
EV/EBITDA
16.22
Net Margin
5.32%
Op. Margin
8.46%
ROA
5.63%
Quick Ratio
8.72
Curr. Ratio
10.14
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Ishita Drugs outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Ishita Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ISHITA DRUGS & INDUSTRIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹14.66₹15.00₹15.19₹12.07
Other Income₹0.47₹0.34₹0.28₹0.20
Total Revenue₹15.13₹15.33₹15.47₹12.27
Total Expenses₹14.05₹14.18₹14.48₹11.49
Profit Before Tax₹1.08₹1.16₹0.99₹0.78
Tax₹0.30₹0.29₹0.24₹0.20
Profit After Tax₹0.78₹0.87₹0.75₹0.58
EPS - Basic₹2.60₹2.90₹2.50₹1.93
EPS - Diluted₹2.60₹2.90₹2.50₹1.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.08₹1.16₹0.99₹0.78
Income before WC changes₹0.80₹1.00₹0.91₹0.76
Change in Assets₹3.89-₹4.86₹1.84-₹2.07
Change in Liabilities-₹0.77₹0.22-₹0.63-₹1.59
Change in WC₹3.12-₹4.64₹1.21-₹3.66
Cash flow from Operations₹3.92-₹3.64₹2.12-₹2.90
Cash flow from Investing-₹2.24-₹0.67₹0.13₹0.59
Cash flow from Financing-₹3.81₹4.33-₹0.87₹1.05
Total Cash Flow-₹2.13₹0.02₹1.38-₹1.25
Cash (Start of the year)₹4.83₹4.81₹3.43₹4.68
Cash (End of the year)₹2.70₹4.83₹4.81₹3.43

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3.06₹1.31₹1.15₹1.23
Current Assets₹9.54₹14.98₹9.66₹10.18
Total Assets₹12.60₹16.30₹10.81₹11.41
Current Liabilities₹0.99₹5.40₹0.87₹2.21
Net Current Asset₹8.55₹9.58₹8.79₹7.96
Non-Current Liabilities₹0.05₹0.10₹0.02₹0.02
Equity Capital₹11.57₹10.79₹9.92₹9.17
Total Equity & Liabilities₹12.60₹16.30₹10.81₹11.41
* All values are in INR Crore
Qty
Bid
101
72.41
200
72.4
300
71.6
100
71.5
20
71.2
Ask
Qty
76.94
6
76.95
105
77
60
78
100
84
5
Bid Total: 721
Ask Total: 276
Buy orders: 72%
Sell orders: 28%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
50.21
Neutral
ATR (14)
1.85
Neutral
STOCH(9,6)
74.5
Neutral
STOCH RSI (14)
91.18
Bearish
ADX(9)
24.02
Bearish
UO(9)
31.38
Neutral
ROC(12)
0.39
Bullish
WillR(14)
-39.18
Neutral
Period
Simple value
Exponential vaue
5D
71.23
71.97
10D
72.48
72.19
20D
72.95
72.66
50D
73.46
73.58
100D
75.61
74.14
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ISHITA DRUGS & INDUSTRIES LTD. Share Price
ISHITA DRUGS & INDUSTRIES LTD.
Pharmaceuticals
Add Stock
Add Another

ISHITA DRUGS & INDUSTRIES LTD. Share Price FAQs

ISHITA DRUGS & INDUSTRIES LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837